A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

Clinical trial NCT00848926 · COMPLETED

Trial details

NCT number: NCT00848926
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Disease, Hodgkin

Start date: 2009-02-01
Primary completion: 2010-08-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.